• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西他赛、异环磷酰胺和奈达铂(DIN)挽救化疗治疗晚期生殖细胞肿瘤患者:初步报告。

Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.

机构信息

Department of Urology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.

出版信息

Jpn J Clin Oncol. 2013 Jul;43(7):734-9. doi: 10.1093/jjco/hyt060. Epub 2013 Apr 25.

DOI:10.1093/jjco/hyt060
PMID:23619987
Abstract

OBJECTIVE

We investigated the efficacy and toxicity of a docetaxel, ifosfamide and nedaplatin regimen as salvage therapy for patients with advanced testicular germ cell tumor.

METHODS

Eleven patients with advanced germ cell tumor refractory or relapsed after cisplatin-based chemotherapy were treated using docetaxel, ifosfamide and nedaplatin. The docetaxel, ifosfamide and nedaplatin regimen comprised docetaxel (75 mg/m(2)) on Day 1, ifosfamide (2 g/m(2)) on Days 1-3 and nedaplatin (75 mg/m(2)) on Day 2 of a 3-week cycle.

RESULTS

Ten (91%) of the 11 patients achieved favorable responses, including complete response in one case and partial response in nine cases. Nine (81%) of the 11 patients have continued to show no evidence of disease after docetaxel, ifosfamide and nedaplatin therapy followed by subsequent surgical resection, with a median follow-up period of 52 months. One patient died of the disease 3 months after completing docetaxel, ifosfamide and nedaplatin chemotherapy. One patient was lost to follow-up with a status of alive with disease. Ten (91%) of the 11 patients developed Grade 4 leukopenia, which was managed using granulocyte colony-stimulating factor. No patients developed sensory neuropathy or renal dysfunction.

CONCLUSIONS

The docetaxel, ifosfamide and nedaplatin regimen was efficacious and well-tolerated as salvage chemotherapy for patients with advanced germ cell tumor.

摘要

目的

我们研究了多西他赛、异环磷酰胺和奈达铂方案作为晚期睾丸生殖细胞肿瘤患者挽救性治疗的疗效和毒性。

方法

11 例晚期生殖细胞肿瘤患者在接受顺铂为基础的化疗后出现耐药或复发,采用多西他赛、异环磷酰胺和奈达铂方案治疗。多西他赛、异环磷酰胺和奈达铂方案包括多西他赛(75mg/m²)第 1 天,异环磷酰胺(2g/m²)第 1-3 天,奈达铂(75mg/m²)第 2 天,每 3 周为 1 个周期。

结果

11 例患者中,10 例(91%)获得了良好的反应,包括 1 例完全缓解和 9 例部分缓解。11 例患者中,9 例(81%)在接受多西他赛、异环磷酰胺和奈达铂治疗后继续无疾病证据,随后进行了手术切除,中位随访时间为 52 个月。1 例患者在完成多西他赛、异环磷酰胺和奈达铂化疗后 3 个月死于疾病。1 例患者失访,存活且有疾病。11 例患者中有 10 例(91%)发生 4 级白细胞减少症,使用粒细胞集落刺激因子治疗。无患者发生感觉神经病或肾功能不全。

结论

多西他赛、异环磷酰胺和奈达铂方案作为晚期生殖细胞肿瘤的挽救性化疗方案是有效且耐受良好的。

相似文献

1
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.多西他赛、异环磷酰胺和奈达铂(DIN)挽救化疗治疗晚期生殖细胞肿瘤患者:初步报告。
Jpn J Clin Oncol. 2013 Jul;43(7):734-9. doi: 10.1093/jjco/hyt060. Epub 2013 Apr 25.
2
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.紫杉醇、异环磷酰胺和顺铂(TIN)对晚期生殖细胞肿瘤患者进行挽救性化疗。
Int J Urol. 2007 Jun;14(6):527-31. doi: 10.1111/j.1442-2042.2006.01702.x.
3
Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.对晚期生殖细胞肿瘤患者采用紫杉醇、异环磷酰胺和顺铂联合挽救性化疗。
Int J Urol. 2015 Mar;22(3):288-93. doi: 10.1111/iju.12665. Epub 2014 Nov 13.
4
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].[以紫杉醇、异环磷酰胺和顺铂进行挽救性化疗用于复发性或难治性生殖细胞癌]
Nihon Hinyokika Gakkai Zasshi. 2006 May;97(4):630-5. doi: 10.5980/jpnjurol1989.97.630.
5
Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.采用紫杉醇、异环磷酰胺和顺铂(TIP)进行挽救性化疗用于复发性或顺铂难治性生殖细胞肿瘤。
Onkologie. 2011;34(8-9):416-20. doi: 10.1159/000331129. Epub 2011 Aug 23.
6
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.紫杉醇、异环磷酰胺和顺铂用于复发性睾丸生殖细胞癌患者的二线治疗。
J Clin Oncol. 2000 Jun;18(12):2413-8. doi: 10.1200/JCO.2000.18.12.2413.
7
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.伊立替康和奈达铂作为晚期生殖细胞肿瘤患者在接受基于顺铂的联合化疗强化治疗后的挽救疗法。
Int J Clin Oncol. 2016 Feb;21(1):162-7. doi: 10.1007/s10147-015-0861-0. Epub 2015 Jun 28.
8
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer.紫杉醇、异环磷酰胺和顺铂方案对日本晚期生殖细胞癌患者是可行的。
Jpn J Clin Oncol. 2003 Mar;33(3):127-31. doi: 10.1093/jjco/hyg029.
9
Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function.对于肾功能受损的难治性或复发性生殖细胞肿瘤患者,紫杉醇、异环磷酰胺加奈达铂的肾毒性较低。
Int J Urol. 2020 Feb;27(2):134-139. doi: 10.1111/iju.14147. Epub 2019 Nov 7.
10
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.联合吉西他滨、顺铂和异环磷酰胺(GIP)治疗复发性转移性生殖细胞肿瘤(GCT)有效:GETUG 前瞻性多中心 II 期试验。
Ann Oncol. 2014 May;25(5):987-91. doi: 10.1093/annonc/mdu099. Epub 2014 Mar 4.

引用本文的文献

1
Overcoming Chemotherapy Resistance in Germ Cell Tumors.克服生殖细胞肿瘤中的化疗耐药性
Biomedicines. 2022 Apr 22;10(5):972. doi: 10.3390/biomedicines10050972.
2
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.贝伐单抗/大剂量化疗联合自体干细胞移植治疗高危复发或难治性生殖细胞肿瘤
Ann Oncol. 2015 Oct;26(10):2125-32. doi: 10.1093/annonc/mdv310. Epub 2015 Jul 21.
3
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
伊立替康和奈达铂作为晚期生殖细胞肿瘤患者在接受基于顺铂的联合化疗强化治疗后的挽救疗法。
Int J Clin Oncol. 2016 Feb;21(1):162-7. doi: 10.1007/s10147-015-0861-0. Epub 2015 Jun 28.